April 20, 2024

Extracorporeal Shock Wave Lithotripsy Market Primed For Growth Driven By Increasing Kidney Stone Cases

The extracorporeal shock wave lithotripsy (ESWL) market provides a non-invasive treatment option for breaking up kidney stones and other types of calculi located outside the kidneys using shockwave technology without incisions. ESWL systems generate shock waves externally to target internal calculi with high-energy pulses that fragment the calculi into smaller, sand-like pieces that can pass through the urinary system naturally. The growing prevalence of kidney stone disease, availability of advanced ESWL systems, and minimally invasive nature of the procedure are driving increased adoption rates globally.

The Global Extracorporeal Shock Wave Lithotripsy Market is estimated to be valued at Us$ 510.34 Mn in 2024 and is expected to exhibit a CAGR Of 7.2% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the extracorporeal shock wave lithotripsy market are William Grant & Sons, Pernod Ricard, Diageo Plc, Bacardi Limited, Suntory Holdings, Aceo Ltd., Ben Nevis Distillery, Edrington, Louis Vuitton Moët Hennessy and Gordon & MacPhail.

The increasing incidence of urolithiasis and nephrolithiasis is a major factor boosting demand for ESWL procedures. According to the National Kidney Foundation, approximately one in 11 people will develop a kidney stone in their lifetime. Easy accessibility and non-invasive nature of ESWL is further driving its adoption over alternative invasive surgeries.

Geographic expansion into emerging markets and increasing availability of advanced ESWL devices are expected to further support the global market growth over the forecast period. Key manufacturers are establishing production facilities and distribution networks in Asian countries to tap the high growth potential in these markets.

Market Key Trends

Technological advancements are a key trend shaping the extracorporeal shock wave lithotripsy market. Manufacturers are focused on developing innovative ESWL systems with improved treatment capabilities. Notable developments include the introduction of electrohydraulic, electromagnetic, and piezoelectric lithotripters offering more effective stone fragmentation. Advanced energy delivery mechanisms enable better targeting of stones and minimize collateral tissue damage. The availability of mobile and portable ESWL devices is also enhancing accessibility in remote locations. Additionally, imaging modalities like ultrasound, fluoroscopy, and CT are being integrated to improve precision and outcome of ESWL treatments. These technological upgrades are expanding the applications of ESWL in treating difficult urinary calculi.

Porter’s Analysis

Threat of new entrants: Low capital requirements for entry as many small suppliers provides services.

Bargaining power of buyers: Buyers have high bargaining power due to availability of treatment alternatives like ureteroscopy and percutaneous nephrolithotripsy.

Bargaging power of suppliers: A few large medical device companies like Siemens Healthineers, Dornier MedTech and STORZ MEDICAL dominates the market.

Threat of new substitutes: None in the short run as ESWL remains the standard non-invasive treatment method for kidney stones.

Competitive rivalry: Intense as major players focus on innovating lithotripsy systems and expanding their geographic presence.

Geographically, North America accounts for the largest share of the global extracorporeal shock wave lithotripsy market in terms of value. Rising incidence of urolithiasis and technological advancements are major factors driving the North American market. Asia Pacific is projected to be the fastest growing regional market during the forecast period. Increasing healthcare expenditure and rising awareness about advanced stone treatment options are expected to fuel market growth in Asia Pacific.

Geographical Regions:

The Global Extracorporeal Shock Wave Lithotripsy Market extracorporeal shock wave lithotripsy market in terms of value is majorly concentrated in developed regions of North America and Europe. The United States represents the single largest market globally owing to early technology adoption and high healthcare spending levels in the country. Germany accounts for a significant share of the European ESWL market.

The Asia Pacific region is identified as the fastest growing geographical market for extracorporeal shock wave lithotripsy. Countries such as China, Japan and India are experiencing rapid gains due to growing incidences of urolithiasis coupled with rising healthcare infrastructure and expenditures. Additionally, increasing medical tourism and presence of key market players are aiding the growth of ESWL market in Asia Pacific.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it